Igi Inc Sample Contracts

AutoNDA by SimpleDocs
WITNESSETH ----------
License Agreement • April 14th, 2004 • Igi Inc • Biological products, (no disgnostic substances) • New Jersey
IGI, INC.
Common Stock Purchase Warrant • April 12th, 1999 • Igi Inc • Biological products, (no disgnostic substances) • Delaware
BACKGROUND
Loan and Security Agreement • April 14th, 2000 • Igi Inc • Biological products, (no disgnostic substances) • Pennsylvania
ARTICLE I
Asset Purchase Agreement • February 7th, 2002 • Igi Inc • Biological products, (no disgnostic substances) • New York
RECITALS
Severance Agreement • August 13th, 2004 • Igi Inc • Biological products, (no disgnostic substances)
IGI, INC.
Warrant Agreement • April 12th, 1999 • Igi Inc • Biological products, (no disgnostic substances) • Delaware
1 2 1. Defined Terms. Capitalized terms used herein, but not defined, shall have the same meaning as ascribed to such terms in the Purchase Agreement.
Pledge and Security Agreement • April 14th, 2000 • Igi Inc • Biological products, (no disgnostic substances) • Maryland
BACKGROUND ----------
Forbearance Agreement • August 24th, 1998 • Igi Inc • Biological products, (no disgnostic substances) • New Hampshire
June 25, 2002
Warrant Agreement • July 11th, 2002 • Igi Inc • Biological products, (no disgnostic substances)

Please note that simultaneously with delivery of this letter, we are delivering a Purchaser Notice under the Note and Equity Purchase Agreement dated as of October 29, 1999 by and among the Company, IGI, and certain of their respective affiliates (the "Note Agreement"). The certificate for the Shares should be issued to "American Capital Strategies, Ltd." unless the Company exercises its right to purchase the Shares in accordance with the Purchaser Notice and Section 9 of the Note Agreement.

RECITALS
License Agreement • April 14th, 2004 • Igi Inc • Biological products, (no disgnostic substances) • Florida
BACKGROUND ----------
Extension Agreement • August 24th, 1998 • Igi Inc • Biological products, (no disgnostic substances) • New Hampshire
AutoNDA by SimpleDocs
TELIGENT, INC. Common Stock (par value $0.01 per share) At Market Issuance Sales Agreement
At Market Issuance Sales Agreement • January 28th, 2021 • Teligent, Inc. • Pharmaceutical preparations • New York
UNDERWRITING AGREEMENT
Underwriting Agreement • June 27th, 2014 • Igi Laboratories, Inc • Biological products, (no disgnostic substances) • New York

IGI Laboratories, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom Roth Capital Partners, LLC and Oppenheimer & Co. Inc. are acting as representatives (the “Representatives”), an aggregate of 4,650,000 authorized but unissued shares (the “Firm Shares”) of common stock, par value $0.01 per share (the “Common Stock”), of the Company. The Company has granted the Underwriters the option to purchase an aggregate of up to 697,500 additional shares of Common Stock (the “Option Shares”) as may be necessary to cover over-allotments made in connection with the offering pursuant to Section 4(b) hereof. The Firm Shares and the Option Shares are collectively referred to as the “Shares.”

REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • December 8th, 2010 • Igi Laboratories, Inc • Biological products, (no disgnostic substances)

This Registration Rights Agreement (this “Agreement”) is made and entered into as of December 8, 2010, by and among IGI Laboratories, Inc., a Delaware corporation (the “Company”) and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).

INDEMNIFICATION AGREEMENT
Indemnification Agreement • March 19th, 2009 • Igi Inc • Biological products, (no disgnostic substances) • Delaware

THIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of March 13, 2009 by and between IGI Laboratories, Inc., a Delaware corporation (the “Company”), and Joyce Erony (“Indemnitee”).

2- 3 (f) Grantor has the unqualified right, power and authority to enter into this Agreement and perform its terms; and
Patent Security Agreement • April 14th, 2000 • Igi Inc • Biological products, (no disgnostic substances) • Pennsylvania
WARRANT
Warrant Agreement • April 14th, 2000 • Igi Inc • Biological products, (no disgnostic substances) • Delaware
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!